These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32587315)

  • 21. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    Snow WM; Dale R; O'Brien-Moran Z; Buist R; Peirson D; Martin M; Albensi BC
    J Alzheimers Dis; 2017; 58(3):841-853. PubMed ID: 28505976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.
    Wengenack TM; Reyes DA; Curran GL; Borowski BJ; Lin J; Preboske GM; Holasek SS; Gilles EJ; Chamberlain R; Marjanska M; Jack CR; Garwood M; Poduslo JF
    Neuroimage; 2011 Jan; 54(1):113-22. PubMed ID: 20728546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
    Braskie MN; Klunder AD; Hayashi KM; Protas H; Kepe V; Miller KJ; Huang SC; Barrio JR; Ercoli LM; Siddarth P; Satyamurthy N; Liu J; Toga AW; Bookheimer SY; Small GW; Thompson PM
    Neurobiol Aging; 2010 Oct; 31(10):1669-78. PubMed ID: 19004525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.
    Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R
    Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
    Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
    Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
    Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
    J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of sex-specific glutamate changes in subregions of hippocampus in an early-stage Alzheimer's disease mouse model using GluCEST MRI.
    Soni ND; Swain A; Juul H; Cao Q; Haris M; Wolk DA; Lee VM; Detre JA; Nanga RPR; Reddy R
    Alzheimers Dement; 2024 Oct; 20(10):7124-7137. PubMed ID: 39262197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
    Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
    Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
    Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D
    Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition.
    Poisnel G; Dhilly M; Moustié O; Delamare J; Abbas A; Guilloteau D; Barré L
    Neurobiol Aging; 2012 Nov; 33(11):2561-71. PubMed ID: 22277262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.
    Okamura N; Yanai K
    IDrugs; 2010 Dec; 13(12):890-9. PubMed ID: 21154149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.